Combined use of AB‐132 (Meturedepa, Turloc) and X irradiation in the management of advanced bronchogenic carcinoma
暂无分享,去创建一个
J. Webster | J. Sokal | L. Stutzman | J. L. Ambrus | C. Ross | Julian L. Ambrus | Humberto A. Velasco | Charles A. Ross | Joseph E. Sokal | Leon Stutzman | H. Velasco
[1] J. Sokal,et al. Clinical experience with a new alkylating agent AB-132, in the treatment of lymphomas and leukemias. , 1962, Cancer chemotherapy reports.
[2] T. Bardos. Consideration of chemical reaction mechanisms in relationship to the biological action of "dual antagonists". , 1962, Biochemical pharmacology.
[3] Ross Ca,et al. Clinical experience with AB-132. , 1962 .
[4] Hall Be,et al. Treatment of far-advanced cancer with 5-fluorouracil, used alone and in combination with irradiation. Incidence and duration of remission and survival-time data in 223 patients. , 1962 .
[5] J. Holland,et al. Combined radiation-chemotherapy for bronchogenic carcinoma--pilot study. , 1962, Cancer chemotherapy reports.
[6] E. Mirand,et al. Effect of Chemotherapeutic Agents on Friend Virus-Induced Leukemia in Mice.∗ , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[7] Allaire Fj,et al. Cancer chemotherapy with 5-fluorouracil alone and in combination with x-ray therapy. , 1961 .
[8] L. Sensenbrenner,et al. One year's clinical experience with 5-fluorouracil and x-ray-a preliminary report. , 1961, Cancer chemotherapy reports.
[9] M. Kligerman. The role of combination radiation and chemotherapy , 1960 .
[10] F. Willett,et al. The potentiation of radiation effects with 5-fluorouracil. , 1960, Cancer chemotherapy reports.
[11] A. Segaloff,et al. ‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents , 1959, Nature.
[12] G. Tarnowski,et al. Combination therapy of malignant tumors with ionizing radiations and chemicals; a review. , 1957, Cancer research.